Loar P V, Reynolds R K
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109-0276, USA.
Int J Gynaecol Obstet. 2007 Oct;99(1):69-74. doi: 10.1016/j.ijgo.2007.06.001. Epub 2007 Aug 28.
Lymph node status is the most important prognostic factor for women with vulvar, cervical and endometrial carcinoma and complete lymph node dissection has historically been an integral part of the surgical treatment of these diseases. Lymphadenectomy can be morbid for patients, who may experience wound breakdown, lymphocyst formation or chronic lymphedema, among other problems. Sentinel lymph node mapping is a newer technology that allows selective removal of the first node draining a tumor thereby allowing a potentially less aggressive procedure to be performed. Sentinel node mapping is well accepted for the management of breast carcinoma and cutaneous melanoma, and has resulted in reduced morbidity without adversely affecting survival. Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies.
淋巴结状态是外阴癌、宫颈癌和子宫内膜癌女性患者最重要的预后因素,从历史上看,完整的淋巴结清扫一直是这些疾病外科治疗的一个组成部分。淋巴结切除术对患者来说可能是病态的,患者可能会出现伤口裂开、淋巴囊肿形成或慢性淋巴水肿等问题。前哨淋巴结定位是一种较新的技术,它允许选择性切除引流肿瘤的首个淋巴结,从而有可能进行侵入性较小的手术。前哨淋巴结定位在乳腺癌和皮肤黑色素瘤的治疗中已被广泛接受,并且在不影响生存率的情况下降低了发病率。目前正在研究将前哨淋巴结定位技术用于妇科癌症的治疗。最近的研究显示了将前哨淋巴结定位技术用于治疗几种妇科恶性肿瘤的前景。